JPMorgan Chase & Co’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-129,906
Closed -$432K 5347
2020
Q3
$432K Buy
129,906
+3,395
+3% +$11.3K ﹤0.01% 3442
2020
Q2
$368K Sell
126,511
-26,782
-17% -$77.9K ﹤0.01% 3410
2020
Q1
$432K Buy
153,293
+26,023
+20% +$73.3K ﹤0.01% 3354
2019
Q4
$413K Sell
127,270
-637,799
-83% -$2.07M ﹤0.01% 3511
2019
Q3
$1.65M Buy
765,069
+632,294
+476% +$1.37M ﹤0.01% 2829
2019
Q2
$405K Buy
132,775
+5,257
+4% +$16K ﹤0.01% 3458
2019
Q1
$474K Sell
127,518
-81,665
-39% -$304K ﹤0.01% 3400
2018
Q4
$606K Sell
209,183
-45,013
-18% -$130K ﹤0.01% 3293
2018
Q3
$669K Buy
254,196
+115,956
+84% +$305K ﹤0.01% 3361
2018
Q2
$323K Sell
138,240
-93,976
-40% -$220K ﹤0.01% 3632
2018
Q1
$683K Sell
232,216
-349,364
-60% -$1.03M ﹤0.01% 3260
2017
Q4
$1.59M Sell
581,580
-165,036
-22% -$452K ﹤0.01% 2837
2017
Q3
$2.54M Sell
746,616
-477,042
-39% -$1.62M ﹤0.01% 2522
2017
Q2
$3.02M Sell
1,223,658
-549,767
-31% -$1.36M ﹤0.01% 2405
2017
Q1
$4.03M Buy
1,773,425
+236,745
+15% +$537K ﹤0.01% 2224
2016
Q4
$3.26M Buy
1,536,680
+1,318,714
+605% +$2.8M ﹤0.01% 2406
2016
Q3
$730K Sell
217,966
-22,973
-10% -$76.9K ﹤0.01% 2867
2016
Q2
$757K Buy
240,939
+10,685
+5% +$33.6K ﹤0.01% 2848
2016
Q1
$767K Buy
230,254
+11,747
+5% +$39.1K ﹤0.01% 2766
2015
Q4
$774K Sell
218,507
-80,237
-27% -$284K ﹤0.01% 2770
2015
Q3
$1.5M Sell
298,744
-2,717
-0.9% -$13.7K ﹤0.01% 2499
2015
Q2
$1.94M Sell
301,461
-459,312
-60% -$2.95M ﹤0.01% 2534
2015
Q1
$5.35M Sell
760,773
-490,586
-39% -$3.45M ﹤0.01% 2067
2014
Q4
$9.65M Buy
1,251,359
+487,499
+64% +$3.76M ﹤0.01% 1715
2014
Q3
$5.71M Buy
763,860
+464,655
+155% +$3.47M ﹤0.01% 1955
2014
Q2
$2.9M Buy
299,205
+209,371
+233% +$2.03M ﹤0.01% 2290
2014
Q1
$747K Sell
89,834
-811,436
-90% -$6.75M ﹤0.01% 2913
2013
Q4
$7.61M Sell
901,270
-192,167
-18% -$1.62M ﹤0.01% 1786
2013
Q3
$8.71M Buy
1,093,437
+46,544
+4% +$371K ﹤0.01% 1731
2013
Q2
$8.08M Buy
+1,046,893
New +$8.08M ﹤0.01% 1671